Track topics on Twitter Track topics that are important to you
Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN) is a neurotechnology innovator focused on the commercialization of two proprietary platforms for direct neural sensing in the brain, real-time neural signal decoding technology, and neural stimulation. The Company's mission is to commercialize products based upon these powerful platform technologies that restore function, including limb movement, sensation and communication, for those with a wide range of central nervous system conditions, diseases and injuries, such as spinal cord injury, ALS and other motor neuron diseases. Cyberkinetics' proprietary neural stimulation technology platform is being developed to regenerate neural fibers that form functional connections, restoring tactile sensation and movement for those with spinal cord injuries and, ultimately, a wide range of central nervous system injuries, diseases and conditions. Cyberkinetics' proprietary neural sensing technology platform provides the ability to sense, transmit, analyze and apply the language of neurons in both short- and long-term settings. Our award-winning technology was originally developed and sold as research products to neuroscientist around the world. Today, we are broadening the application of our technology to develop clinical products. We pride ourselves on a Management Team and Board of Directors with proven track records at leading medical device and biotechnology companies. Cyberkinetics is publicly traded on the Over the Counter Bulletin Board under the ticker symbol, CYKN. The Company is headquartered in Foxborough, Massachusetts, and conducts engineering, research and manufacturing operations in Salt Lake City, Utah.
100 Foxborough Boulevard, Suite 240
United States of America
Reported by: Irina Robu, PhD The 3D printer we think more frequently in combination with PCBs is the DragonFly 2020 from Nano Dimension which works with different with all kinds of materials in additi...
VILNIUS, Lithuania, June 12, 2017 /PRNewswire/ -- Neurotechnology, a provider of high-precision biometric identification technologies, today added a new Extreme edition to its MegaMatcher Acceler...
VILNIUS, Lithuania, Aug. 20, 2012 /PRNewswire/ -- Neurotechnology, a provider of high-precision biometric identification, object recognition and computer vision technologies, today announced the ...
VILNIUS, Lithuania, June 26, 2017 /PRNewswire/ -- The Ultrasound Research Group at Neurotechnology today announced that it is developing a new, patent-pending ultrasonic 3D printing technolo...
ArticleIt was baseball that first drew Will Rosellini to the field of neurotechnology. Staff Aut
VILNIUS, Lithuania, June 14, 2017 /PRNewswire/ -- A team of deep neural network researchers from Neurotechnology won first place in a Kaggle competition that sought cutting-edge AI solutions for ...
JERUSALEM INTERNATIONAL CONVENTION CENTER, Israel, September 12, 2012 /PRNewswire/ -- Israel Brain Technologies (IBT), a new initiative inspired by the vision of Israeli President Shimon Peres, is an...
The purpose of this study is to use remote methods and scalable interactive neurotechnology to generate important data on the potential for remote targeted cognitive treatment in people wi...
Welcome to the Cambridge Neurotechnology web site. Cambridge Neurotechnology was founded in 1995 and in 1996 introduced the Actiwatch activity monitoring system. As the first truly light-weight system...
The Neurotechnology Industry Organization is the trade association that represents companies involved in neuroscience including software, drugs, devices, and diagnostics, brain re...
SAM TECHNOLOGY, Inc. (SAM) is a privately held neurotechnology R&D lab located in downtown San Francisco. Founded in 1986 by Alan Gevins, an MIT engineer and internationally known neuroscientist, SAM ...
Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN) is a neurotechnology innovator focused on the commercialization of two proprietary platforms for direct neural sensing in the brain, real-time ...
We have published hundreds of Cyberkinetics Neurotechnology news stories on BioPortfolio along with dozens of Cyberkinetics Neurotechnology Clinical Trials and PubMed Articles about Cyberkinetics Neurotechnology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cyberkinetics Neurotechnology Companies in our database. You can also find out about relevant Cyberkinetics Neurotechnology Drugs and Medications on this site too.
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase 'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...
Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...